Maturitas
Volume 55, Issue 1 , Pages 58-68 , 20 August 2006

Use, intentions, and beliefs about hormone replacement therapy in women with and without diabetes

  • Sally A. Huston

      Affiliations

    • Department of Pharmaceutical Sciences, School of Pharmacy, South University, 709 Mall Boulevard, Savannah, GA 31406, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 912 201 8134; fax: +1 912 201 8153.
    • ,
  • Duane M. Kirking

      Affiliations

    • Center for Medication Use Policy and Economics, Department of Social and Administrative Sciences, College of Pharmacy, University of Michigan, 428 Church St., Ann Arbor, MI 48109-1065, United States
    • ,
  • Leslie A. Shimp

      Affiliations

    • College of Pharmacy, University of Michigan, 428 Church St., Ann Arbor, MI 48109-1065, United States

Received 15 September 2005 ,Revised 3 January 2006 ,Accepted 3 January 2006.

References 

  1. Watkins ES. Dispensing with aging: changing rationales for long-term hormone replacement therapy, 1960–2000. Pharm Hist. 2001;43:23–37
  2. American College of Obstetricians and Gynecologists . American College of Obstetricians and Gynecologists educational bulletin: hormone replacement therapy. Am Coll Obstetricians Gynecologists. 1998;247:1–10
  3. Guidelines for counseling postmenopausal women about preventive hormone therapy. American College of Physicians. Ann Inter Med 1992;117(12):1038–1041.
  4. U.S. Preventive Services Task Force . Guide to clinical preventive services: report of the U.S. Preventive Services Task Force. 2nd ed.. Baltimore: Williams & Wilkins; 1996;
  5. Austin PC, Mamdani MM, Tu K, Jankiimainen L. Research letter. Prescriptions for estrogen replacement therapy in Ontario before and after publication of the women's health initiative study. JAMA. 2003;289:3241–3242
  6. Whitlock EP, Johnson RE, Vogt TM. Recent patterns of hormone replacement therapy use in a large managed care organization. J Women's Health. 1998;7:1017–1026
  7. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280(7):605–613
  8. Writing Group for the Women's Health Initiative. Investigators risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA. 2002;288:321–333
  9. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy. Annual trends and response to recent evidence. JAMA. 2004;291:47–53
  10. Barrett-Connor E, Hendrix S, Ettinger B, et al. Best Clinical Practices. Chapter 13 from the International Position Paper on Women's Health and Menopause: A Comprehensive Approach. National Heart, Lung, and Blood Institute, National Institutes of Health Office of Research on Women's Health, and Giovanni Lorenzini Medical Science Foundation. 2002. http://www4.od.nih.gov/orwh/. Access date: 5-27-2002.
  11. The North American Menopause Society, Alternatives to Hormone Replacement Therapy: Suggestions from The North American Menopause Society; 2002. http://www.menopause.org/alternatives_hrt.html. Access date: 10-23-2002.
  12. Kaplan S. A model of person–environment compatibility. Environ Behav. 1983;15:311–332
  13. Keating NL, Cleary PD, Rossi AS, Zaslavskky AM, Ayanian JZ. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Inter Med. 1999;130:545–553
  14. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998;338:1516–1520
  15. Robinson JG, Folsom AR, Nabulsi AA, Watson R, Brancati FL, Cai J. Can postmenopausal hormone replacement improve plasma lipids in women with diabetes?. Diabetes Care. 1996;19:480–485
  16. Stafford RS, Saglam D, Causino N, Blumenthal D. Low rates of hormone replacement in visits to United States primary care physicians. Am J Obstet Gynecol. 1997;177:381–387
  17. North American Menopause Society. Effects of menopause and estrogen replacement therapy or hormone replacement therapy in women with diabetes mellitus: consensus opinion of the North American menopause society. Menopause: J North Am Menopause Soc. 2000;7:87–95
  18. Kaplan RC, Heckbert SR, Weiss NS, et al. Postmenopausal estrogens and risk of myocardial infarction in diabetic women. Diabetes Care. 1998;21:1117–1121
  19. Lawrenson RA, Leydon GM, Newson RB, Feher MD. Coronary heart disease in women with diabetes: positive association with past hysterectomy and possible benefits of hormone replacement therapy. Diabetes Care. 1999;22:856–857
  20. Lobo RA. Estrogen and cardiovascular disease. Ann N Y Acad Sci. 1990;592:272–285
  21. Nabulsi AA, Folsom AR, White A, et al. Association of hormone-replacement therapy with various cardiovascular risk factors in post-menopausal women: the atherosclerosis risk in communities study investigators. N Engl J Med. 1993;328:1069–1075
  22. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prevent Med. 1991;20:47–63
  23. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986
  24. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853
  25. Steil CF. Diabetes mellitus. In:  DiPiro JT,  Talbert RL,  Yee GC, et al. editor. Pharmacotherapy: a pathophysiologic approach. Stamford, CT: Appleton and Lange; 1999;p. 1219–1243
  26. Krakauer JC, McKenna MJ, Buderer NF, Rao DS, Whitehouse FW, Parfitt AM. Bone loss and bone turnover in diabetes. Diabetes. 1995;44:775–782
  27. Sayinalp S, Gedik O, Koray Z. Diabetic osteopenia: pathophysiology and clinical aspects. Diab Metab Rev. 1995;11:21–35
  28. Dunne FP. Should women with diabetes mellitus receive hormone replacement therapy?. Int J Clin Pract. 1997;51:299
  29. Espeland MA, Hogan PE, Fineberg SE, et al. PEPI investigators effect of postmenopausal hormone therapy on glucose and insulin concentrations. Diabetes Care. 1998;21:1589–1595
  30. Ferrara A, Barrett-Connor E, Wingard DL, Edelstein SL. Sex differences in insulin levels in older adults and the effect of body size, estrogen replacement therapy, and glucose tolerance status: the Rancho Bernardo study, 1984–1987. Diabetes Care. 1995;18:220–225
  31. Manson JE, Rimm EB, Colditz GA, et al. A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus. Ann Epidemiol. 1992;2:665–673
  32. Phillips P. Diabetes and the menopause. Aust Fam Physician. 1998;27:59–63
  33. Huston SA, Sleath B, Rubin RH. Physician gender and hormone replacement therapy discussion. J Women's Health Gender-Based Med. 2001;10:279–287
  34. Garamszegi C, Dennerstein E, Dudley E, Guthrie JR, Ryan M, Burger H. Menopausal status: subjectively and objectively defined. J Psychosom Obstet Gynaecol. 1998;19:165–173
  35. Sparks P, Guthrie CA, Shepherd R. The dimensional structure of the perceived behavioral control construct. J Appl Soc Psychol. 1997;27:418–438
  36. Dillman DA. Mail and internet surveys. The tailored design method. 2nd ed.. New York: John Wiley & Sons, Inc.; 2000;
  37. Montano DE, Kasprzyk D. The theory of reasoned action and the theory of planned behavior. In: Glanz K, Rimer BK, Lewis FM, editors. Health behavior and health education. 3rd ed. San Francisco: Jossey-Bass; 2002. p. 67–98 [chapter 4].
  38. Spatz BA, Denis LT, Byrne J, Page BJ. Use of the theory of planned behavior to explain HRT decisions. Am J Health Behav. 2003;27:445–455
  39. Levens E, Williams S. Current opinions and understandings of menopausal women about hormone replacment therapy (HRT)—The University of Floriday experience. Am J Obstet Gynecol. 2004;191:641–647
  40. Visser AP, Hofland I, Gehring B, et al. The continuation of hormone replacement therapy: a compliance study of Dutch and Belgian climacteric women. J Reprod Infant Psychol. 1995;13:135–146
  41. Svenson O. Differentiation and consolidation theory of human decision making: a frame of reference for the study of pre- and post-decision processes.. Acta Psychol. 1992;80:143–168
  42. O’Keefe DJ. Persuasion: theory & research. 2nd ed.. Thousand Oaks: Sage; 2002;
  43. Legato MJ, Emrika P, Slaughter E. Women's perceptions of their general health, with special reference to their risk of coronary artery disease: results of a national telephone survey. J Women's Health. 1997;6:189–198

PII: S0378-5122(06)00008-9

doi: 10.1016/j.maturitas.2006.01.004

Maturitas
Volume 55, Issue 1 , Pages 58-68 , 20 August 2006

Article Tools